Pravastatin attenuates isoprenaline induced cardiac fibrosis in a mouse model

References

• Abe Y, Izumi T, Urabe A, Nagai M, Taniguchi I, Ikewaki K, Mochizuki S. 2006. Pravastatin prevents myocardium from ischemia-induced fibrosis by protecting vascular endothelial cells exposed to oxidative stress. Cardiovasc Drugs Ther. 20:273–280. doi: 10.1007/s10557-006-9525-7.
   PubMed Web of Science ®Google Scholar
• Akbar MIA, Yosediputra A, Pratama RE, Fadhilah NL, Sulistyowati S, Amani FZ, Dachlan EG, Dikman Angsar M, Dekker GA. 2021. Pravastatin suppresses inflammatory cytokines and endothelial activation in patients at risk of developing preeclampsia: INOVASIA study. J Matern Fetal Neonat Med. 31:1–8. doi: 10.1080/14767058.2021.1879785.
   Google Scholar
• Banerjee I, Fuseler JW, Intwala AR, Baudino TA. 2009. IL- 6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart. Am J Physiol Heart Circ Physiol. 296:H1694–H1704. doi: 10.1152/ajpheart.00908.2008.
   PubMed Web of Science ®Google Scholar
• Benton JA, Kern HB, Leinwand LA, Mariner PD, Anseth KS. 2009. Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler Thromb Vasc Biol. 29:1950–1957. doi: 10.1161/ATVBAHA.109.195271.
   PubMed Web of Science ®Google Scholar
• Bergt S, Grub A, Wagner S, Engelke H, Nöldge-Schomburg G, Vollmar B, Roesner JP, Wagner NM. 2017. Pravastatin but not simvastatin improves survival and neurofunctional outcome after cardiac arrest and cardiopulmonary resuscitation. Basic Transl Sci. 2:149–159. doi: 10.1016/j.jacbts.2017.01.009.
   PubMedGoogle Scholar
• Buege JA, Aust SD. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52:302–310.
   PubMedGoogle Scholar
• Caorsi C, Pineda F, Munoz C. 2008. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytok Netw. 19:99–103.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ohmori K, Mizukawa M, Yoshida J, Zeng Y, Zhang L, Shinomiya K, Kosaka H, Kohno M. 2007. Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes. Circ J. 71:144–152. doi: 10.1253/circj.71.144.
   PubMed Web of Science ®Google Scholar
• Christia P, Bujak M, Gonzalez-Quesada C, Chen W, Dobaczewski M, Reddy A, Frangogiannis NG. 2013. Systematic characterization of myocardial inflammation, repair and remodeling in a mouse model of re-perfused myocardial infarction. J Histochem Cytochem. 61:555–570. doi: 10.1369/0022155413493912.
   PubMed Web of Science ®Google Scholar
• Crespo MJ, Quidgley J. 2015. Simvastatin, atorvastatin, and pravastatin equally improve the hemodynamic status of diabetic rats. World J Diabetes. 6:1168–1178. doi: 10.4239/wjd.v6.i10.1168.
   PubMed Web of Science ®Google Scholar
• Ding YY, Li JM, Guo FJ, Liu Y, Tong YF, Pan XC, Lu XL, Ye W, Chen XH, Zhang HG. 2016. Triptolide upregulates myocardial forkhead helix transcription factor p3 expression and attenuates cardiac hypertrophy. Front Pharmacol. 7:471. doi: 10.3389/fphar.2016.00471.
   PubMed Web of Science ®Google Scholar
• Eberlein M, Heusinger-Ribeiro J, Goppelt-Struebe M. 2001. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMGCoA reductase inhibitors (statins). Br J Pharmacol. 133:1172–1180. doi: 10.1038/sj.bjp.0704173.
   PubMed Web of Science ®Google Scholar
• El-Mahdy N, Salem ML, El-Sayad M, El-Desouky KI, Zaghow N. 2016. Bone marrow mononuclear cells enhance anti-inflammatory effects of pravastatin against isoproterenol-induced myocardial infarction in rats. J Immunotoxicol. 13:393–402. doi: 10.3109/1547691X.2015.1111959.
   PubMed Web of Science ®Google Scholar
• Elnakish MT, Hassona MD, Alhaj MA, Moldovan L, Janssen PM, Khan M, Hassanain HH. 2012. Rac-induced left ventricular dilation in thyroxin-treated ZmRacD transgenic mice: role of cardiomyocyte apoptosis and myocardial fibrosis. PLoS One. 7:e42500. doi: 10.1371/journal.pone.0042500.
   PubMed Web of Science ®Google Scholar
• Fang T, Guo B, Xue L, Wang L. 2019. Atorvastatin prevents myocardial fibrosis in spontaneous hypertension via interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3)/endothelin-1 (ET-1) pathway. Med Sci Monit. 25:318–323. doi: 10.12659/MSM.912032.
   PubMed Web of Science ®Google Scholar
• Hu K, Wan Q. 2019. Biphasic influence of pravastatin on human cardiac microvascular endothelial cell functions under pathological and physiological conditions. Biochem Biophys Res Commun. 511:476–481. doi: 10.1016/j.bbrc.2019.02.090.
   PubMed Web of Science ®Google Scholar
• Iwata A, Shirai R, Ishii H, Kushima H, Otani S, Hashinaga K, Umeki K, Kishi K, Tokimatsu I, Hiramatsu K, Kadota J. 2012. Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells. Clin Exp Immunol. 168:234–240. doi: 10.1111/j.1365-2249.2012.04564.x.
   PubMed Web of Science ®Google Scholar
• Kawasaki Y, Imaizumi T, Matsuura H, Ohara S, Takano K, Suyama K, Hashimoto K, Nozawa R, Suzuki H, Hosoya M. 2008. Renal expression of alpha-smooth muscle actin and c-Met in children with Henoch–Schönlein purpura nephritis. Pediatr Nephrol. 23:913–919. doi: 10.1007/s00467-008-0749-6.
   PubMed Web of Science ®Google Scholar
• Khachadurian AK, Shimamura T, Rozovski SJ, Ananthakrishnan R, Armenian B, Coly E, AlHinai A, Martucci C, Schneider SH, Amorosa LF. 1991. Pravastatin decreases serum lipids and vascular cholesterol deposition in watanabe heritable hyperlipidemic (WHHL) rabbits. Jpn Heart J. 32:675–685. doi: 10.1536/ihj.32.675.
   PubMedGoogle Scholar
• Khalil MI, Tanvir EM, Afroz R, Sulaiman SA, Gan SH. 2015. Cardioprotective effects of tualang honey: amelioration of cholesterol and cardiac enzymes levels. BioMed Res Int. 2015:286051. doi: 10.1155/2015/286051.
   PubMed Web of Science ®Google Scholar
• Kräker K, O’Driscoll JM, Schütte T, Herse F, Patey O, Golic M, Geisberger S, Verlohren S, Birukov A, Heuser A, Müller DN, Thilaganathan B, Dechend R, Haase N. 2020. Statins reverse postpartum cardiovascular dysfunction in a rat model of preeclampsia. Hypertension. 75:202–210. doi: 10.1161/HYPERTENSIONAHA.119.13219.
   PubMed Web of Science ®Google Scholar
• Kuo HF, Hsieh CC, Wang SC, Chang CY, Hung CH, Kuo PL, Liu YR, Li CY, Liu PL. 2019. Simvastatin attenuates cardiac fibrosis via regulation of cardiomyocyte-derived exosome secretion. J Clin Med. 8:794. doi: 10.3390/jcm8060794.
   PubMed Web of Science ®Google Scholar
• Li H, Wang C, Sun J, Liu C, Li N, Chen J. 2018a. Pravastatin decreases infarct size induced by coronary artery ischemia/reperfusion with elevated eNOS expression in rats. Int Heart J. 59:154–160. doi: 10.1536/ihj.16-607.
   PubMed Web of Science ®Google Scholar
• Li M, Liu F, Sang M, Sun X, Li L, Wang X. 2018b. Effects of atorvastatin on p38 phosphorylation and cardiac remodeling after myocardial infarction in rats. Exp Ther Med. 16:751–757. doi: 10.3892/etm.2018.6201.
   PubMed Web of Science ®Google Scholar
• Lillie RD. 1940. Biebrich scarlet-picro-aniline blue: a new differential connective tissue and muscle stain. Arch Pathol. 29:705–705.
   Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real time quantitative PCR and the 2-∆∆CT method. Methods. 25:02–408. doi: 10.1006/meth.2001.1262.
   Web of Science ®Google Scholar
• Luna LG. 1968. Manual of histologic staining methods of the Armed Forces Institute of Pathology. 3rd ed. McGraw-Hill, New York; p. 258.
   Google Scholar
• Luo R, Sun X, Shen F, Hong B, Wang Z. 2020. Effects of high-dose rosuvastatin on ventricular remodeling and cardiac function in ST-segment elevation myocardial infarction. Drug Des Dev Ther. 14:3891–3898. doi: 10.2147/DDDT.S254948.
   PubMed Web of Science ®Google Scholar
• Ma D, Zheng B, Du H, Han X, Zhang X, Zhang J, Gao Y, Sun S, Chu L. 2020. The mechanism underlying the protective effects of tannic acid against isoproterenol-induced myocardial fibrosis in mice. Front Pharmacol. 11:716. doi: 10.3389/fphar.2020.00716.
   PubMed Web of Science ®Google Scholar
• Mansouri E, Jangaran A, Ashtari A. 2017. Protective effect of pravastatin on doxorubicin-induced hepatotoxicity. Bratisl Lek Listy. 118:273–277. doi: 10.4149/BLL_2017_054.
   PubMed Web of Science ®Google Scholar
• Min JJ, Shin BS, Lee JH, Jeon Y, Ryu DK, Kim S, Shin YH. 2018. Effects of pravastatin on type 1 diabetic rat heart with or without blood glycemic control. J Diabetes Res. 2018:1067853. doi: 10.1155/2018/1067853.
   PubMed Web of Science ®Google Scholar
• Ning BB, Zhang Y, Wu DD, Cui JG, Liu L, Wang PW, Wang WJ, Zhu WL, Chen Y, Zhang T. 2017. Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice. Acta Pharmacol Sin. 38:331–341. doi: 10.1038/aps.2016.142.
   PubMed Web of Science ®Google Scholar
• Oi M, Donner D, Peart J, Beck B, Wendt L, Headrick JP, du Toit EF. 2018. Pravastatin improves risk factors but not ischaemic tolerance in obese rats. Eur J Pharmacol. 826:148–157. doi: 10.1016/j.ejphar.2018.02.050.
   PubMed Web of Science ®Google Scholar
• Ota H, Eto M, Kano MR, Kahyo T, Setou M, Ogawa S, Iijima K, Akishita M, Ouchi Y. 2010. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler Thromb Vasc Biol. 30:2205–2211. doi: 10.1161/ATVBAHA.110.210500.
   PubMed Web of Science ®Google Scholar
• Qin YW, Ye P, He JQ, Sheng L, Wang LY, Du J. 2010. Simvastatin inhibited cardiac hypertrophy and fibrosis in apolipoprotein E-deficient mice fed a “Western-style diet” by increasing PPAR α and γ expression and reducing TC, MMP-9, and Cat S levels. Acta Pharmacol Sin. 31:1350–1358. doi: 10.1038/aps.2010.109.
   PubMed Web of Science ®Google Scholar
• Raziyeva K, Kim Y, Zharkinbekov Z, Temirkhanova K, Saparov A. 2022. Novel therapies for the treatment of cardiac fibrosis following myocardial infarction. Biomedicines. 10:2178. doi: 10.3390/biomedicines10092178.
   PubMed Web of Science ®Google Scholar
• Santosh K, Jahangir MA, Pankaj P, Subir KM, Shyamal KG. 2017. Terminalia arjuna (Roxb.) reverses the molecular signature of fibrosis induced by isoproterenol in rat heart. Am J Phytomed Clin Ther. 5:22.
   Google Scholar
• Sedlak J, Lindsay RH. 1968. Estimation of total, protein bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 25:192–205. doi: 10.1016/0003-2697(68)90092-4.
   PubMed Web of Science ®Google Scholar
• Sharma M, Singh TU, Rana A, Kuma T, Gari M, Mani P, Lingaraju MC, Parida S, Singh V, Sahoo M, Kumar D. 2023. Biochanin‐A alleviates fibrosis and inflammation in cardiac injury in mice. J Biochem Mol Toxicol. 37:e23360. doi: 10.1002/jbt.23360.
   PubMed Web of Science ®Google Scholar
• Sun F, Duan W, Zhang Y, Zhang L, Qile M, Liu Z, Qiu F, Zhao D, Lu Y, Chu W. 2015. Simvastatin alleviates cardiac fibrosis induced by infarction via up-regulation of TGF-β receptor III expression. Br J Pharmacol. 172:3779–3792. doi: 10.1111/bph.13166.
   PubMed Web of Science ®Google Scholar
• Sun TL, Li WQ, Tong XL, Liu XY, Zhou WH. 2021. Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway. Eur J Pharmacol. 891:173690. doi: 10.1016/j.ejphar.2020.173690.
   PubMed Web of Science ®Google Scholar
• Trojan PJ, Bohatch-Junior MS, Otuki MF, Souza-Fonseca-Guimarães F, Svidnick PV, Nogaroto V, Fernandes D, Krum EA, Favero GM. 2016. Pravastatin induces cell cycle arrest and decreases production of VEGF and bFGF in multiple myeloma cell line. Braz J Biol. 76:59–65. doi: 10.1590/1519-6984.11914.
   PubMed Web of Science ®Google Scholar
• Tuerdi N, Xu L, Zhu B, Chen C, Cao Y, Wang Y, Zhang Q, Li Z, Qi R. 2016. Preventive effects of simvastatin nanoliposome on isoproterenol-induced cardiac remodeling in mice. Nanomed Nanotechnol Biol Med. 12:1899–1907. doi: 10.1016/j.nano.2016.05.002.
   PubMed Web of Science ®Google Scholar
• Variya BC, Patel SS, Trivedi JI, Gandhi HP, Rathod SP. 2015. Comparative evaluation of HMG CoA reductase inhibitors in experimentally-induced myocardial necrosis: biochemical, morphological and histological studies. Eur J Pharmacol. 764:283–291. doi: 10.1016/j.ejphar.2015.07.024.
   PubMed Web of Science ®Google Scholar
• Walton KL, Johnson KE, Harrison CA. 2017. Targeting TGF-β mediated SMAD signaling for the prevention of fibrosis. Front Pharmacol. 8:461. doi: 10.3389/fphar.2017.00461.
   PubMed Web of Science ®Google Scholar
• Wang LX, Yang X, Yue Y, Fan T, Hou J, Chen GX, Liang MY, Wu ZK, Katare RG. 2017. Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model. PLoS One. 12:e0178619. doi: 10.1371/journal.pone.0178619.
   PubMed Web of Science ®Google Scholar
• Wang QW, Yu XF, Xu HL, Zhao XZ, Sui DY. 2019. Ginsenoside Re improves isoproterenol-induced myocardial fibrosis and heart failure in rats. Evid Based Comple Alt Med. 2019:3714508. doi: 10.1155/2019/3714508.
   PubMed Web of Science ®Google Scholar
• Xu H, Shen Y, Liang C, Wang H, Huang J, Xue P, Luo M. 2021. Inhibition of the mevalonate pathway improves myocardial fibrosis. Exp Ther Med. 21:224. doi: 10.3892/etm.2021.9655.
   PubMed Web of Science ®Google Scholar
• Xu Z, Okamoto H, Akino M, Onozuka H, Matsui Y, Tsutsui H. 2008. Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice. J Cardiovasc Pharmacol. 51:62–70. doi: 10.1097/FJC.0b013e31815bb629.
   PubMed Web of Science ®Google Scholar
• Yang T, Chen M, Sun T. 2013. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells. Cell Physiol Biochem. 31:863–874. doi: 10.1159/000350104.
   PubMed Web of Science ®Google Scholar
• Yu B, Yu M, Zhang H, Xie D, Nie W, Shi K. 2020. Suppression of miR-143-3p contributes to the anti-fibrosis effect of atorvastatin on myocardial tissues via the modulation of Smad2 activity. Exp Mol Pathol. 112:104346. doi: 10.1016/j.yexmp.2019.104346.
   PubMed Web of Science ®Google Scholar
• Yu Y, Ohmori K, Chen Y, Sato C, Kiyomoto H, Shinomiya K, Takeuchi H, Mizushige K, Kohno M. 2004. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model. J Am Coll Cardiol. 44:904–913. doi: 10.1016/j.jacc.2004.04.050.
   PubMed Web of Science ®Google Scholar
• Zhang GX, Kimura S, Nishiyama A, Shokoji T, Rahman M, Yao L, Nagai Y, Fujisawa Y, Miyatake A, Abe Y. 2005. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res. 65:230–238. doi: 10.1016/j.cardiores.2004.08.013.
   PubMed Web of Science ®Google Scholar
• Zhang N, Wei WY, Li LL, Hu C, Tang QZ. 2018. Therapeutic potential of polyphenols in cardiac fibrosis. Front Pharmacol. 9:122. doi: 10.3389/fphar.2018.00122.
   PubMed Web of Science ®Google Scholar
• Zhao H, Liao Y, Minamino T, Asano Y, Asakura M, Kim J, Asanuma H, Takashima S, Hori M, Kitakaze M. 2008. Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress. Hypertens Res. 31:1977–1987. doi: 10.1291/hypres.31.1977.
   PubMed Web of Science ®Google Scholar
• Zuo S, Li L, Jiang L, Jiang C, Li X, Li S, Wen S, Ba R, Du X, Dong J, Liu N, Ruan Y, Ma C. 2020. Pravastatin alleviates intracellular calcium dysregulation induced by interleukin-6 via the mitochondrial ROS pathway in adult ventricular myocytes. J Pharmacol Sci. 143:141–147. doi: 10.1016/j.jphs.2020.01.013.
   PubMed Web of Science ®Google Scholar
• Zuo Z, Ji MY, Zhao K, Su ZP, Li P, Hou DR, Li Y. 2019. CD47 deficiency attenuates isoproterenol-induced cardiac remodeling in mice. Oxid Med Cell Longev. 19:7121763. doi: 10.1155/2019/7121763.
   Google Scholar